Profil
Valerie Salentey is currently the Director of Regulatory Affairs & Quality Assurance at Sensorion SA since 2020.
Prior to this, she worked as the Head of Regulatory Affairs at Neovacs SA from 2018 to 2020, Head of Regulatory Affairs at PPD France SAS in 2018, and Head of Regulatory Affairs at Genethon from 2016 to 2018.
She also worked as the Head of Regulatory Affairs at Cytheris SA from 2008 to 2013.
Aktiva positioner av Valerie Salentey
| Företag | Position | Start |
|---|---|---|
| SENSORION | Generell Rådgivare | 2020-04-01 |
Tidigare kända positioner av Valerie Salentey
| Företag | Position | Slut |
|---|---|---|
| NEOVACS | Generell Rådgivare | 2020-03-01 |
PPD France SAS
PPD France SAS Miscellaneous Commercial ServicesCommercial Services Provides technical analyzes,tests and inspection services | Generell Rådgivare | 2018-10-01 |
Genethon
Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Generell Rådgivare | 2018-01-01 |
Cytheris SA
Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation | Generell Rådgivare | 2013-08-01 |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Cytheris SA
Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation | Health Technology |
Neovacs SA
Neovacs SA Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapies | Health Technology |
PPD France SAS
PPD France SAS Miscellaneous Commercial ServicesCommercial Services Provides technical analyzes,tests and inspection services | Commercial Services |
Sensorion SA
Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Genethon
Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Health Technology |
















